Vraylar (cariprazine) is a prescription drug that helps treat certain mental health conditions. The drug comes as an oral capsule. Vraylar may not be safe to take while pregnant or breastfeeding.

Keep reading to learn more about Vraylar and reproductive health. And for a detailed overview of this drug, check out this article.

If you can become pregnant, it’s important to consider whether Vraylar is a safe option for you.

Vraylar may not be safe to take while pregnant. The drug’s use during pregnancy hasn’t been studied.

If you’re pregnant or planning to become pregnant, talk with your doctor. They’ll explain the risks and benefits of Vraylar.

If you take Vraylar during pregnancy, consider joining the National Pregnancy Registry for Psychiatric Medications. This registry collects information about the safety of antipsychotic drugs during pregnancy. To learn more about this pregnancy registry, talk with your doctor. You can also call 866-961-2388, or visit the registry’s website.

If you’re currently breastfeeding or planning to do so, it’s important to understand the effects that Vraylar could have on you or the child who’s breastfed.

It’s not known whether Vraylar is safe to take while breastfeeding. The drug’s effects on breast milk and children who are breastfed haven’t been studied.

If you’re breastfeeding or planning to breastfeed, talk with your doctor. They’ll help you decide on a treatment or feeding plan that’s right for you and your child.

Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.